Comparable stake leader
VALLEY FORGE INVESTMENT CONSULTANTS INC ADV
SEC ownership of NERVGEN PHARMA CORP.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001751912.
Disclosed value leader
VALLEY FORGE INVESTMENT CONSULTANTS INC ADV
Comparable rows
0/36
Latest evidence
30 Sep 2026
- Public ticker
- NGEN on Nasdaq
- Parsed ownership sources
-
13F
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
VALLEY FORGE INVESTMENT CONSULTANTS INC ADV
Ranking: Comparable ownership first, then disclosed value
- Latest parsed ownership date
-
30 Sep 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001751912
- Issuer location
- Vancouver
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
1 signal
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of NERVGEN PHARMA CORP. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
VALLEY FORGE INVESTMENT C...
Disclosed value leader
VALLEY FORGE INVESTMENT C...
Comparable rows
0/36
Latest evidence
30 Sep 2026
13F
Highest disclosed value: $1,593,238
36 rows are not safely comparable across share classes.
Showing 1-8 of 36 holder rows.
Quick read
VALLEY FORGE INVESTMENT CONSULTANTS INC ADV has the largest disclosed position value at $1.59M.
0 of 36 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens VALLEY FORGE INVESTMENT CONSULTANTS INC ADV's linked filing trail.
Disclosed position value
Top 5
VALLEY FORGE INVESTMENT CONSULTAN...
$1.59M
MARSHALL WACE, LLP
$1.18M
PFG Investments, LLC
$463.2K
Stonepine Capital Management, LLC
$382K
GEODE CAPITAL MANAGEMENT, LLC
$128.8K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-8 of 36 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| VALLEY FORGE INVESTMENT CONSULTANTS INC ADV |
13F
Company
|
—
denominator unverified
|
$1,593,238
834,156 shares
|
— | 30 Sep 2026 |
| MARSHALL WACE, LLP |
13F
Company
|
—
denominator unverified
|
$1,178,954
617,253 shares
|
— | 30 Sep 2026 |
| PFG Investments, LLC |
13F
Company
|
—
denominator unverified
|
$463,175
242,500 shares
|
— | 30 Sep 2026 |
| Stonepine Capital Management, LLC |
13F
Company
|
—
denominator unverified
|
$382,000
200,000 shares
|
— | 30 Sep 2026 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
denominator unverified
|
$128,827
67,449 shares
|
— | 30 Sep 2026 |
| CAPTRUST FINANCIAL ADVISORS |
13F
Company
|
—
denominator unverified
|
$124,950
65,419 shares
|
— | 30 Sep 2026 |
| COMMONWEALTH EQUITY SERVICES, LLC |
13F
Company
|
—
denominator unverified
|
$120,330
63,000 shares
|
— | 30 Sep 2026 |
| STATE STREET CORP |
13F
Company
|
—
denominator unverified
|
$117,083
61,300 shares
|
— | 30 Sep 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
No eligible buy or sell activity is available for this window. No eligible Buy or Sell transactions are available in this dataset since 15 Nov 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Recent insider transactions for NERVGEN PHARMA CORP.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||
* marks a reported price that did not pass the local price check.